Targeting cannabinoid agonists for inflammatory and neuropathic pain (Q28307619)

Expert Opinion on Investigational Drugs

Europe PubMed Central

title

Targeting cannabinoid agonists for inflammatory and neuropathic pain (English)

0 references

0 references

0 references

0 references

Yuan Cheng

1

0 references

Stephen A Hitchcock

series ordinal

2

0 references

language of work or name

English

0 references

publication date

July 2007

0 references

published in

0 references

volume

16

0 references

issue

7

0 references

page(s)

951-65

0 references

cites work

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

Identification and functional characterization of brainstem cannabinoid CB2 receptors

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.16.7.951

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Signal transduction activated by cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

CB2 cannabinoid receptor mediation of antinociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Cannabinoid agonists attenuate capsaicin-induced responses in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Adamantyl cannabinoids: a novel class of cannabinergic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

C-Attached aminoalkylindoles: potent cannabinoid mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Design, Synthesis and Pharmacology of Cannabimimetic Indoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

The search for selective ligands for the CB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

C-3 Amido-indole cannabinoid receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Rational Design and Synthesis of an Orally Active Indolopyridone as a Novel Conformationally Constrained Cannabinoid Ligand Possessing Antiinflammatory Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.951

10.1517/13543784.16.7.951

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17594182

1 reference

Consolidated OpenCitations Corpus – April 2017